Previous 10 | Next 10 |
TAMPA, Fla. and MENLO PARK, Calif., May 30, 2023 (GLOBE NEWSWIRE) -- Morphogenesis, Inc. (“Morphogenesis”), a privately-held Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment modulators to overcome resistance to c...
NEW YORK, NY / ACCESSWIRE / May 25, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Prometheus Biosciences, Inc. (NASDAQ:RXDX...
2023-05-24 12:53:19 ET Gainers: Minority Equality Opportunities Acquisition ( MEOA ) +176% . Enveric Biosciences ( ENVB ) +82% . QuantaSing Group ( QSG ) +61% . EpicQuest Education Group ( EEIQ ) +51% . GigaCloud Technology ( GCT ) ...
2023-05-24 10:07:34 ET Gainers: Enveric Biosciences ( ENVB ) +100% . Zura Bio ( ZURA ) +37% . Kamada ( KMDA ) +19% . Organogenesis ( ORGO ) +16% . OptimizeRx ( OPRX ) +14% . Losers: PTC Therapeutics ( PTCT ) -24% ....
2023-05-24 08:38:01 ET CohBar ( CWBR ) -22% . HeartCore Enterprises ( HTCR ) -21% . Navitas Semiconductor Corporation NVTS -20% commences $80M public offering . PTC Therapeutics PTCT -19% abandons preclinical gene therapy programs, cuts staff; C...
CohBar, Inc. (NASDAQ: CWBR) is one of today's top gainers. The company's shares are currently up 120.65% on the day to $3.42. CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and...
2023-05-23 10:08:04 ET Gainers: CohBar ( CWBR ) +157% . Ocean Biomedical ( OCEA ) +79% . Shuttle Pharmaceuticals ( SHPH ) +46% . Icosavax ( ICVX ) +31% . Recursion Pharmaceuticals ( RXRX ) +20% . Losers: NantHealth ( ...
2023-05-23 08:50:23 ET CohBar ( NASDAQ: CWBR ) is merging with privately held personalized cancer vaccine developer Morphogenesis and the combined company is expected to operate under the name TuHURA Biosciences Inc. Under the agreement, each holder of CohBar common stock will b...
Combined company will operate under the name “TuHURA Biosciences, Inc.” and advance a personalized cancer vaccine platform and preclinical tumor microenvironment modulators Lead asset, IFx-Hu2.0 , expected to enter Phase 2/3 registration trial as first-line treatment for Mer...
CohBar, Inc. (CWBR) Q3 2022 Results Conference Call November 8, 2022 10:00 AM ET Company Participants Jordyn Tarazi - Director of IR Joseph Sarret - CEO Kent Grindstaff - SVP, Research Jeffrey Biunno - CFO Conference Call Participants Kemp Dollive...
News, Short Squeeze, Breakout and More Instantly...
3D Systems Corporation (DDD) is expected to report $-0.11 for Q1 2024 ZW Data Action Technologies Inc. (CNET) is expected to report for Q1 2024 Celularity Inc. (CELU) is expected to report for Q1 2023 DMK Pharmaceuticals Corporation (DMKPQ) is expected to report for Q1 2024 Atlant...
ADDvantage Technologies Group Inc. (AEYGQ) is expected to report for Q1 2024 ContraFect Corporation (CFRXQ) is expected to report for Q1 2024 American Clean Resources Group Inc (ACRG) is expected to report for Q1 2024 Atlantic Lithium Ltd Ord Fully Paid (ALLIF) is expected to report f...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...